摘要
目的:探讨噻托溴铵联合沙美特罗/氟替卡松治疗哮喘-慢阻肺重叠综合征的临床效果。方法:收治哮喘-慢阻肺重叠综合征患者100例,随机分为对照组和试验组,每组各50例。对照组采用常规药物治疗,试验组采用噻托溴铵联合沙美特罗/氟替卡松治疗。结果:治疗后,试验组患者的肺部功能明显优于对照组,且生活质量明显高于对照组(P<0.05)。结论:噻托溴铵联合沙美特罗/氟替卡松治疗哮喘-慢阻肺重叠综合征的临床效果显著。
Objective:To explore the clinical effect of tiotropium bromide combined with salmeterol/fluticasone in the treatment of asthma-COPD overlapping syndrome.Methods:100 patients with asthma-COPD overlapping syndrome were selected and randomly divided into the control group and the experimental group.The control group was treated with conventional drugs,and the experimental group was treated with tiotropium bromide combined with salmeterol/fluticasone.Results:After treatment,the pulmonary function of the experimental group was significantly better than that of the control group,and the quality of life was significantly higher than that of the control group(P<0.05).Conclusion:The clinical effect of tiotropium bromide combined with salmeterol/fluticasone in the treatment of asthma-COPD overlapping syndrome was significant.
作者
程丽
Cheng Li(Big Department of Internal Medicine,the Second People's Hospital of Xiaonan District,Xiaogan City,Hubei Province 432100)
出处
《中国社区医师》
2018年第30期26-27,共2页
Chinese Community Doctors
